efmoroctocog alfa Vials, injection Upon request
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #13160
It is an international biopharmaceutical company focused on rare diseases. They are dedicated to providing access to innovative treatments that transform the lives of people with rare diseases. They focus on two therapeutic areas – hematology and immunology – and also have a portfolio of specialty care products. They have in-house capabilities that stretch from late-stage R&D, biologics manufacturing and supply, to patient access and distribution.